FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1584545275> ?p ?o ?g. }

• W1584545275 endingPage "7231" @default.
• W1584545275 startingPage "7221" @default.
• W1584545275 abstract "// Julian Burks 1,2 , Ryan E. Reed 1 and Shyamal D. Desai 1 1 Department of Biochemistry & Molecular Biology, LSU Health Sciences Center-School of Medicine, New Orleans, LA, USA 2 Present Address: Georgetown University Medical Center, Lombardi Comprehensive Cancer Center Department of Molecular Oncology, Washington, DC, USA Correspondence: Shyamal D. Desai, email: // Keywords : ISG15, Ubiquitin/proteasome, Antitumor, Immune system, Breast cancer Received : January 07, 2015 Accepted : January 13, 2015 Published : January 31, 2015 Abstract Interferon-Stimulated Gene 15 (ISG15), an antagonist of the canonical ubiquitin pathway, is frequently overexpressed in various cancers. In cancer cells, ISG15 is detected as free (intracellular) and conjugated to cellular proteins (ISGylation). Free ISG15 is also secreted into the extracellular milieu. ISGylation has protumor functions and extracellular free ISG15 has immunomodulatory properties in vitro . Therefore, whether ISG15 is a tumor suppressor or tumor promoter in vivo remains controversial. The current study aimed to clarify the role of free ISG15 in tumorigenesis. Breast cancer cells stably expressing control, ISG15, and UbcH8 (ISG15-specific E2 ligase) shRNAs were used to assess the immunoregulatory and antitumor function of free ISG15 in cell culture ( in vitro ) and in nude mice ( in vivo ). We show that extracellular free ISG15 suppresses breast tumor growth and increases NK cell infiltration into xenografted breast tumors in nude mice, and intracellular free ISG15 enhances major histocompatibility complex (MHC) class I surface expression in breast cancer cells. We conclude that free ISG15 may have antitumor and immunoregulatory function in vivo . These findings provides the basis for developing strategies to increase systemic levels of free ISG15 to treat cancer patients overexpressing the ISG15 pathway." @default.
• W1584545275 created "2016-06-24" @default.
• W1584545275 creator A5003747504 @default.
• W1584545275 creator A5004255747 @default.
• W1584545275 creator A5040523725 @default.
• W1584545275 date "2015-01-31" @default.
• W1584545275 modified "2023-10-01" @default.
• W1584545275 title "Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective" @default.
• W1584545275 cites W1521491171 @default.
• W1584545275 cites W1527289043 @default.
• W1584545275 cites W1538826344 @default.
• W1584545275 cites W1545435534 @default.
• W1584545275 cites W1625891503 @default.
• W1584545275 cites W1909639357 @default.
• W1584545275 cites W1964362318 @default.
• W1584545275 cites W1965049147 @default.
• W1584545275 cites W1965577503 @default.
• W1584545275 cites W1977105782 @default.
• W1584545275 cites W1978085575 @default.
• W1584545275 cites W1984678830 @default.
• W1584545275 cites W1988344957 @default.
• W1584545275 cites W2005765588 @default.
• W1584545275 cites W2007666820 @default.
• W1584545275 cites W2012032483 @default.
• W1584545275 cites W2015824748 @default.
• W1584545275 cites W2018274817 @default.
• W1584545275 cites W2018926341 @default.
• W1584545275 cites W2021381786 @default.
• W1584545275 cites W2027470770 @default.
• W1584545275 cites W2034831347 @default.
• W1584545275 cites W2036928562 @default.
• W1584545275 cites W2041638315 @default.
• W1584545275 cites W2047813242 @default.
• W1584545275 cites W2051227636 @default.
• W1584545275 cites W2058005401 @default.
• W1584545275 cites W2068335768 @default.
• W1584545275 cites W2072280896 @default.
• W1584545275 cites W2078844752 @default.
• W1584545275 cites W2079100129 @default.
• W1584545275 cites W2081202846 @default.
• W1584545275 cites W2092647031 @default.
• W1584545275 cites W2097802843 @default.
• W1584545275 cites W2098727982 @default.
• W1584545275 cites W2103433909 @default.
• W1584545275 cites W2118863472 @default.
• W1584545275 cites W2125812410 @default.
• W1584545275 cites W2126775019 @default.
• W1584545275 cites W2132800040 @default.
• W1584545275 cites W2137579180 @default.
• W1584545275 cites W2143618144 @default.
• W1584545275 cites W2148313173 @default.
• W1584545275 cites W2149627334 @default.
• W1584545275 cites W2151026134 @default.
• W1584545275 cites W2155665993 @default.
• W1584545275 cites W2156520195 @default.
• W1584545275 cites W2596151792 @default.
• W1584545275 doi "https://doi.org/10.18632/oncotarget.3372" @default.
• W1584545275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4466680" @default.
• W1584545275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25749047" @default.
• W1584545275 hasPublicationYear "2015" @default.
• W1584545275 type Work @default.
• W1584545275 sameAs 1584545275 @default.
• W1584545275 citedByCount "57" @default.
• W1584545275 countsByYear W15845452752015 @default.
• W1584545275 countsByYear W15845452752016 @default.
• W1584545275 countsByYear W15845452752017 @default.
• W1584545275 countsByYear W15845452752018 @default.
• W1584545275 countsByYear W15845452752019 @default.
• W1584545275 countsByYear W15845452752020 @default.
• W1584545275 countsByYear W15845452752021 @default.
• W1584545275 countsByYear W15845452752022 @default.
• W1584545275 countsByYear W15845452752023 @default.
• W1584545275 crossrefType "journal-article" @default.
• W1584545275 hasAuthorship W1584545275A5003747504 @default.
• W1584545275 hasAuthorship W1584545275A5004255747 @default.
• W1584545275 hasAuthorship W1584545275A5040523725 @default.
• W1584545275 hasBestOaLocation W15845452751 @default.
• W1584545275 hasConcept C104317684 @default.
• W1584545275 hasConcept C121608353 @default.
• W1584545275 hasConcept C126322002 @default.
• W1584545275 hasConcept C203014093 @default.
• W1584545275 hasConcept C207001950 @default.
• W1584545275 hasConcept C25602115 @default.
• W1584545275 hasConcept C2780718723 @default.
• W1584545275 hasConcept C502942594 @default.
• W1584545275 hasConcept C530470458 @default.
• W1584545275 hasConcept C54355233 @default.
• W1584545275 hasConcept C555283112 @default.
• W1584545275 hasConcept C71924100 @default.
• W1584545275 hasConcept C86803240 @default.
• W1584545275 hasConcept C8891405 @default.
• W1584545275 hasConceptScore W1584545275C104317684 @default.
• W1584545275 hasConceptScore W1584545275C121608353 @default.
• W1584545275 hasConceptScore W1584545275C126322002 @default.
• W1584545275 hasConceptScore W1584545275C203014093 @default.
• W1584545275 hasConceptScore W1584545275C207001950 @default.
• W1584545275 hasConceptScore W1584545275C25602115 @default.
• W1584545275 hasConceptScore W1584545275C2780718723 @default.

• next